Myriad and the Future of Patent Eligibility
A Bloomberg Law Expert Insights Event
Wednesday, May 1, 2013
8:00 AM – 10:00 AM
Following April 15 oral arguments in Myriad, the United States Supreme Court will be poised to rule on the patentability of the isolated human gene. Bloomberg Law’s Expert Insights event will bring together Washington leaders in patent law to address the future of patent eligibility in light of Myriad and the Court’s 2012 decision in Mayo.
Panel discussion to be moderated by Tony Dutra, Legal Editor, BNA’s Patent, Trademark & Copyright Journal®.
Follow us @BLOOMBERGLAW and join the conversation